HIV vaccine preparedness studies in the organization for economic co-operation and development (OECD) countries

AIDS Care - Psychological and Socio-Medical Aspects of AIDS/HIV

Volumn 19, Issue 9, 2007, Pages 1118-1127

  Dhalla, S ^a   Woods, R ^b   Strathdee, S A ^c   Patrick, D M ^a,d   Hogg, R S ^e  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b Canadian HIV Trials Network   (Canada)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d BRITISH COLUMBIA CENTRE FOR DISEASE CONTROL   (Canada)

^e BRITISH COLUMBIA CENTRE FOR EXCELLENCE IN HIV AIDS   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

HUMAN IMMUNODEFICIENCY VIRUS VACCINE; RGP 120; UNCLASSIFIED DRUG; VCP 205;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; DRUG USE; ECONOMIC DEVELOPMENT; FEMALE; HEALTH CARE ORGANIZATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MALE; PATIENT ASSESSMENT; PRIORITY JOURNAL; RISK FACTOR; SEXUAL BEHAVIOR; SYSTEMATIC REVIEW;

ACQUIRED IMMUNODEFICIENCY SYNDROME; AIDS VACCINES; DEVELOPED COUNTRIES; DEVELOPING COUNTRIES; FEMALE; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HETEROSEXUALITY; HOMOSEXUALITY, MALE; HUMANS; MALE; SUBSTANCE ABUSE, INTRAVENOUS; UNSAFE SEX;

EID: 36849034875     PISSN: 09540121     EISSN: 13600451     Source Type: Journal    
DOI: 10.1080/09540120701352258     Document Type: Article

References (36)

1. Ackers, M.L., Parekh, B., Evans, T.G., Berman, P., Phillips, S., Allen, M., et al. (2003). Human Immunodeficiency Virus (HIV) Seropositivity Among Uninfected HIV Vaccine Recepients. Journal of Infectious Diseases, 187, 879-86.
2. Bartholow, B.N., MacQueen, K.M., Douglas, J.M., Buchbinder, S., McKirnan, D., & Judson, F.N. (1997). Assessment of the Changing Willingness to Participate in Phase III HIV Vaccine Trials Among Men Who Have Sex with Men. Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology, 16, 108-15.
3. Brown-Peterside, P., Chiasson, M.A., Ren, L., & Koblin, B.A. (2000). Involving Women in HIV Vaccine Efficacy Trials: Lessons Learned From A Vaccine Preparedness Study in New York City. Journal of Urban Health, 77(3), 425-36.
4. Brown-Peterside, P., Rivera, E., Lucy, D., Slaughter, I., Ren, L., Chiasson, M.A., et al. (2001). Retaining Hard-To-Reach Women in HIV Prevention and Vaccine Trials: Project ACHIEVE. American Journal of Public Health, 91(9), 1377-79.
5. Buchbinder, S.P., Douglas, J.M., McKirnan, D.J., Judson, F.N., Katz, M.H., & McQueen, K.M. (1996). Feasiblility of Human Immunodeficiency Virus Vaccine Trials in Homosexual Men in the United States: Risk Behavior, Seroincidence, and Willingness to Participate. Journal of Infecious Diseases, 174, 954-61.
6. Buchbinder, S.P., Metch, B., Holte, S.E., Scheer, S., Coletti, A., & Vittinghoff, E. (2004). Determinants of Enrollment in a Preventive HIV Vaccine Trial: Hypothetical Versus Actual Willingness and Barriers to Participation. Journal of Acquired Immune Deficiency Syndromes, 36(1), 604-12.
7. Francis, D.P., Heyward, W.L., Popovic, V., Orozco-Cronin, P., Orelind, K., & Gee, C., et al. (2003). Candidate HIV/AIDS Vaccines: Lessons Learned from the World's Phase 3 Efficacy Trials. AIDS, 17, pp. 147-56.
8. Golub, E.T., Purvis, L.A., Sapun, M., Safaeian, M., Beyrer, C., Vlahov, D., et al. (2005). Changes in Willingness to Participate in HIV Vaccine Trials Among HIV-Negative Injection Drug Users. AIDS and Behavior, 9(3), 301-9.
9. Gross, M., Seage, G.R., Mayer, K.A., Goldstein, R.S., Losina, E., & Wold. (1996). Interest Among Gay/Bisexual Men in Greater Boston in Participating in Clinical Trials of Preventive HIV Vaccines. Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology, 12, pp. 406-12.
10. Hays, R.B., & Kegeles, S.M. (1999). Factors Related to the Willingness of Young Gay Men to Participate in Preventive HIV Vaccine Trials. Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology, 20(2), 164-71.
11. Harrison, K., Vlahov, D., Jones, K., Charron, K., & Clements, M.L. (1995). Medical Eligibility, Comprehension of the Consent Process, and Retention of Injection Drug Users Recruited for an HIV Vaccine Trial. Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology, 10, 386-90.
12. Jermano, J. (2000). Monitoring of Social and Behavioral Harms in the Phase 3 Trial of AIDVAX (r) B/B Presented at the XIII International AIDS Conference, Durban, South Africa, July, 2000.
13. Koblin, B.A., Taylor, P.E., Avrett, S., & Stevens, C.E. (1996). The Feasibility of HIV-1 Vaccine Efficacy Trials Among Gay/Bisexual Men in New York City: Project Achieve. AIDS, 10, 1555-61.
14. Koblin, B.A., Avrett, S., & Taylor, P.E. (1997). Willingness to Participate in HIV-1 Vaccine Efficacy Trials and the Effect of Media Events Among Gay and Bisexual Men in New York City: Project Achieve. Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology, 15, 165-71.
15. Koblin, B.A., Heagerty, P., Sheon, A., Buchbinder, S., Celum, C., Douglas, J.M., et al. (1998). Readiness of High-Risk Populations in the HIV Network for Prevention Trials to Participate in HIV Vaccine Efficacy Trials in the United States., AIDS, 12, 785-93.
16. Koblin, B.A., Holte, S., Lenderking, B., & Heagerty, P. (2000). Readiness for HIV Vaccine Trials: Change in Willingness and Knowledge Among High-Risk Populations in the HIV Network for Prevention Trials. Journal of Acquired Immune Deficiency Syndromes, 24, 451-57.
17. Marmor, M., Titus, S., Wolfe, H., Krasinski, K., Maslansky, R., Simberkoff, M., et al. (1994). Retention, Behavior Change and HIV-Seroconversion Among Injecting Drug Users (IDUs) and Sexual Partners of IDUs. AIDS Research and Human Retroviruses, 110(Suppl 2), S207-S213.
18. Meyers, K., Metzger, D.S., Navaline, H., Woody, G.E., & McLellan, A.T. (1994). HIV Vaccine Trials: Will Intravenous Drug Users Enroll? American Journal of Public Health, 84(5), 761-66.
19. Meyers, K., Metzger, D.S., McLellan, T., Navaline, H., Sheon, A.R., & Woody, G.E. (1995). Will Preventive HIV Vaccine Efficacy Trials Be Possible With Female Injection Drug Users? Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology, 10, 577-85.
20. Mills, E., Cooper, C., Guyatt, G., Gilchrist, A., Rachlis, B., Sulway, C., et al. (2004). Barriers to Participation in an HIV Vaccine Trial: A Systematic Review. AIDS, 18, 2235-42.
21. O'Connell, J.M, Hogg, R.S., Chan, K., Strathdee, S.A., McLean, N., Martindale, S.L., et al. (2002). Willingness to Participate and Enroll in a Phase 3 Preventive HIV-1 Vaccine Trial. Journal of Immune Deficiency Syndromes, 31, 521-8.
22. O'Connor, P.G., Meankzija, B., Poling, J., Kosten, T.R., Fitzgerald, B., & Rounsaville, B.J. (1995). HIV Vaccine Preparedness Trials in Injection-Drug Users: Are We Prepared. Substance Abuse, 16(4), 195-203.
23. Rida, W., Fast, P., Hoff, R., & Fleming, T. (1997). Intermediate-Size Trials for the Evaluation of HIV Vaccine Candidates: A Workshop Summary. Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology, 16(3), 195-203.
24. Scheer, S., Douglas, J.M., Vittinghoff, E., Bartholow, B.N., McKirnan, D., Judson, F.N., et al. (1999). Feasibility and Suitability of Targeting Young Gay Men for HIV Vaccine Efficacy Trials. Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology, 20(2), 172-78.
25. Seage, G.R., Holte, S.E., Metzger, D., Koblin, B.A., Gross, M., Celum, C., et al. (2001). Are US Populations Appropriate for Trials of Human Immunodeficiency Virus Vaccine? American Journal of Epidemiology, 153(7), 619-27.
26. Serpelloni, G., Vlahov, D., Mazzi, M., & Rezza, G. (1995). Interest in HIV Vacccines Among Italian Injection Drug Users. Journal of Acquired Immune Deficiency Syndromes, 10(2), 206-7.
27. Sherr, L., Bolding, G., & Elford, J. (2004). Recruiting London Gay Men Into An HIV Vaccine Trial Is it Feasible? AIDS Care, 16(5), 565-71.
28. Starace, F., Wagner, T.M., Luzi, A.M., Cafaro, L., Gallo, P., & Rezza, G. (2006). Knowledge and Attitudes Regarding Preventive HIV Vaccine Clinical Trials in Italy: Results of a National Survey. AIDS Care, 18(1), 66-72.
29. STEP study at: http://www.stepstudies.com/new/about.shtml
30. Strathdee, S.A., Hogg, R.S., Cornelisse, P.G., Martindale, S.L., Currie, S.L., O'Shaugnessy, M.V., et al. (2000). Factors Associated with Willingness to Participate in HIV Vaccine Trials Among HIV-Negative Injection Drug Users and Young Gay and Bisexual Men. AIDS and Behavior, 4(3), 271-78.
31. Tello, J., Soong, S., Hunter, B., Meriwether, R., Hook, E.W., & Mulligan, M.J. (1998). HIV Vaccine Acceptance Among Heterosexual Clients of a Sexually Transmitted Diseases Clinic. Amercian Journal of Medical Sciences, 315(1), 11-16.
32. UNAIDS at www.unaids.org
33. Van De Ven, P., Bartholow, B., Rawstorne, P., Crawford, J., Kippax, S., Grulich, A., et al. (2002). Scaling HIV Vaccine Attitudes Among Gay Men in Sydney, Australia. AIDS Research and Human Retroviruses, 18(18), 1333-37.
34. Van De Ven, P., Mao, L., Crawford, J., Prestage, G., Grulich, A., Kaldor, J., et al. (2005). Willingness to Participate in HIV Vaccine Trials Among HIV-Negative Gay Men in Sydney, Australia. International Journal of STD and AIDS, 16, 314-17.
35. Vlahov, D., Astemborski, J., Solomon, L., Galai, N., Basarab, L., & Nelson, K.E. (1994). Interest in HIV Vaccines Among Injection Drug Users in Baltimore, Maryland. AIDS Research and Human Retroviruses, 10(Suppl.2), S265-S269.
36. Woody, G.E., Metzger, D., & Mulvaney (1994). Preparation For AIDS Vaccine Trial: Recruitment and Retention of In- and Out-of-Treatment Injection Drug Users. AIDS Research and Human Retroviruses, 10(Suppl.2): S197-S199.